Antimicrobial Susceptibility Testing Market Growth and Business Opportunities for New Market Entrants

Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products.

The global antimicrobial susceptibility testing market is expected to reach USD 3.47 billion by 2022 from USD 2.71 billion in 2017, at a CAGR of 5.1%.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984&utm_source=openpr-26-2-20&utm_medium=openpr

Disk diffusion segment is expected account for the largest share.

By method, the market is segmented into disk diffusion, dilution, ETEST, automated susceptibility testing, and genotypic methods. The disk diffusion segment is expected to dominate the AST market with a share in 2017. Growth in this segment can largely be attributed to its low cost and the flexible nature of these methods.

Manual antimicrobial susceptibility testing segment is estimated to account for the largest share of the market by product in 2017.

The AST market is segmented on the basis of product into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The manual antimicrobial susceptibility testing products segment is expected to command the largest share of the global AST market in 2017. The large share of this segment is attributed to the benefits these products offer such as low cost, ease of use, reduced labor cost, and the compatibility of manual susceptibility testing products with a wide range of organisms.

Antibacterial testing segment is expected account for the largest share of the market.

The global antimicrobial susceptibility testing market is segmented by type into antibacterial, antifungal, antiparasitic, and other susceptibility testing types (mycobacterium and virus). The antibacterial testing segment dominated the market in 2017. The largest share of this market can be attributed to factors such as increasing prevalence of infections due to bacterial pathogens and increasing guidelines streamlining the process of AST.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=206359984&utm_source=openpr-26-2-20&utm_medium=openpr

North America is expected to account for the largest share of the antimicrobial susceptibility testing market during the forecast period.

The report covers the antimicrobial susceptibility testing market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global AST market primarily due to easy accessibility and better adoption of technologically advanced susceptibility testing methods and products.

The increasing prevalence of antimicrobial resistance in North America is another key factor supporting the growth of this regional segment in the global antimicrobial susceptibility testing market. The Asia Pacific is expected to grow at the fastest CAGR as markets in developed countries are increasingly becoming saturated and manufacturers and suppliers of AST products are shifting their focus towards the Asian market.

Leading Companies

Prominent players in the antimicrobial susceptibility testing market include bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), Bio-Rad (US), Hi-Media (India), MERLIN (Germany), Liofilchem (Italy), Accelerate (US), Alifax (Italy), Creative Diagnostics (US), Merck Group(Germany), Synbiosis (UK), Bioanalyse (Turkey), and Zhuhai DL Biotech (China).

Contact Us:
Mr. Sanjay Gupta
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com

About MarketsandMarkets(TM)
MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.